| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |